XML 10 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 13,919 $ 6,585 $ 46,540 $ 17,022
General and administrative 4,345 3,754 13,057 10,574
Total operating expenses 18,264 10,339 59,597 27,596
Loss from operations (18,264) (10,339) (59,597) (27,596)
Other income net 2,765 1,275 7,817 3,640
Net loss $ (15,499) $ (9,064) $ (51,780) $ (23,956)
Net loss per share, basic $ (0.24) $ (0.21) $ (0.86) $ (0.55)
Net loss per share, diluted $ (0.24) $ (0.21) $ (0.86) $ (0.55)
Weighted average common shares outstanding, basic 63,806,158 43,903,738 60,399,697 43,899,670
Weighted average common shares outstanding, diluted 63,806,158 43,903,738 60,399,697 43,899,670
Comprehensive loss:        
Net Income (Loss) $ (15,499) $ (9,064) $ (51,780) $ (23,956)
Other comprehensive gain (loss):        
Unrealized gain (loss) on marketable securities 508 (5) 277 38
Total other comprehensive gain (loss) 508 (5) 277 38
Total comprehensive loss $ (14,991) $ (9,069) $ (51,503) $ (23,918)